These symptoms can feel overwhelming, leaving many women searching for relief
Have your levels checked at your postpartum visit and supplement if needed
GLP-1s are also in development for several novel therapeutic areas
Clinical evidence: key trials and outcomes The kidney-protective potential of SGLT2 inhibitors was first identified in cardiovascular outcome trials, including Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus PatientsRemoving Excess Glucose (EMPA-REG OUTCOME) [36], Canagliflozin Cardiovascular Assessment Study (CANVAS) [37], and Dapagliflozin Effect on Cardiovascular EventsThrombolysis in Myocardial Infarction 58 (DECLARETIMI 58) [38]
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down
As your digestion slows and your appetite decreases, you may experience side effects like nausea, bloating, stomach pain, indigestion, or constipation